Additional studies comparing these radiopharmaceuticals are needed, particularly to evaluate in which phase of sarcoidosis (acute or chronic) 68Ga labeled SSTR2 PET/CT will be more beneficial than FDG. The gene discussed is SSTR2; the disease is sarcoidosis.